4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile oxalate (CAS No: 717133-32-9) is a key pharmaceutical intermediate used in the synthesis of APIs Citalopram and Escitalopram. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile;oxalic acid
CAS No: 717133-32-9
PubChem CID: 16047607
Mol Formula: C22H25FN2O6
Mol Weight: 432.4 g/mol
Used in APIs: Citalopram and Escitalopram
IUPAC Name: 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile;oxalic acid
API Intermediate Description: 4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile oxalate is primarily used as a pharmaceutical intermediate, specifically as a precursor or related compound in the synthesis of antidepressants like Citalopram and its enantiomer Escitalopram, often serving as a reference standard, a potential impurity, or a building block in drug development. It's a complex organic molecule with specific properties (like fluorescence) that aid in pharmaceutical analysis and synthesis.
